AMGEN INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Amgen Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2010 to Q2 2024.
  • Amgen Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $746M, a 45.9% decline year-over-year.
  • Amgen Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $3.13B, a 60.8% decline year-over-year.
  • Amgen Inc annual Net Income (Loss) Attributable to Parent for 2023 was $6.72B, a 2.52% increase from 2022.
  • Amgen Inc annual Net Income (Loss) Attributable to Parent for 2022 was $6.55B, a 11.2% increase from 2021.
  • Amgen Inc annual Net Income (Loss) Attributable to Parent for 2021 was $5.89B, a 18.9% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $3.13B $746M -$633M -45.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $3.76B -$113M -$2.95B -104% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-07
Q4 2023 $6.72B $767M -$849M -52.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $7.57B $1.73B -$413M -19.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-31
Q2 2023 $7.98B $1.38B +$62M +4.71% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $7.92B $2.84B +$1.37B +92.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-07
Q4 2022 $6.55B $1.62B -$283M -14.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $6.84B $2.14B +$259M +13.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $6.58B $1.32B +$853M +184% Apr 1, 2022 Jun 30, 2022 10-Q 2023-10-31
Q1 2022 $5.72B $1.48B -$170M -10.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-10-31
Q4 2021 $5.89B $1.9B +$284M +17.6% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $5.61B $1.88B -$137M -6.78% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $5.75B $464M -$1.34B -74.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-04
Q1 2021 $7.09B $1.65B -$179M -9.81% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-04
Q4 2020 $7.26B $1.62B -$88M -5.17% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-09
Q3 2020 $7.35B $2.02B +$53M +2.69% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $7.3B $1.8B -$376M -17.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-03
Q1 2020 $7.68B $1.83B -$167M -8.38% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-03
Q4 2019 $7.84B $1.7B -$225M -11.7% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-09
Q3 2019 $8.07B $1.97B +$109M +5.86% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-09
Q2 2019 $7.96B $2.18B -$117M -5.1% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-09
Q1 2019 $8.08B $1.99B -$319M -13.8% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-09
Q4 2018 $8.39B $1.93B +$6.19B Oct 1, 2018 Dec 31, 2018 10-K 2020-02-12
Q3 2018 $2.2B $1.86B -$162M -8.02% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-12
Q2 2018 $2.36B $2.3B +$145M +6.74% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-12
Q1 2018 $2.22B $2.31B +$240M +11.6% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-12
Q4 2017 $1.98B -$4.26B -$6.2B -320% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-13
Q3 2017 $8.18B $2.02B +$4M +0.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-13
Q2 2017 $8.17B $2.15B +$281M +15% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-13
Q1 2017 $7.89B $2.07B +$171M +9% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-13
Q4 2016 $7.72B $1.94B +$135M +7.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-13
Q3 2016 $7.59B $2.02B +$154M +8.27% Jul 1, 2016 Sep 30, 2016 10-K 2018-02-13
Q2 2016 $7.43B $1.87B +$217M +13.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-02-13
Q1 2016 $7.22B $1.9B +$277M +17.1% Jan 1, 2016 Mar 31, 2016 10-K 2018-02-13
Q4 2015 $6.94B $1.8B +$506M +39.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-14
Q3 2015 $6.43B $1.86B +$619M +49.8% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-14
Q2 2015 $5.81B $1.65B +$106M +6.85% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-14
Q1 2015 $5.71B $1.62B +$550M +51.3% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-14
Q4 2014 $5.16B $1.29B +$273M +26.7% Oct 1, 2014 Dec 31, 2014 8-K 2016-10-31
Q3 2014 $4.89B $1.24B -$124M -9.06% Jul 1, 2014 Sep 30, 2014 8-K 2016-10-31
Q2 2014 $5.01B $1.55B +$289M +23% Apr 1, 2014 Jun 30, 2014 8-K 2016-10-31
Q1 2014 $4.72B $1.07B -$361M -25.2% Jan 1, 2014 Mar 31, 2014 8-K 2016-10-31
Q4 2013 $5.08B $1.02B +$233M +29.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-19
Q3 2013 $4.85B $1.37B +$261M +23.6% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-19
Q2 2013 $4.59B $1.26B -$8M -0.63% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-19
Q1 2013 $4.6B $1.43B +$250M +21.1% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-19
Q4 2012 $4.35B $788M -$146M -15.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-02-24
Q3 2012 $4.49B $1.11B +$653M +144% Jul 1, 2012 Sep 30, 2012 10-K 2014-02-24
Q2 2012 $3.84B $1.27B +$96M +8.21% Apr 1, 2012 Jun 30, 2012 10-K 2014-02-24
Q1 2012 $3.74B $1.18B +$59M +5.24% Jan 1, 2012 Mar 31, 2012 10-K 2014-02-24
Q4 2011 $3.68B $934M -$88M -8.61% Oct 1, 2011 Dec 31, 2011 10-K 2013-02-27
Q3 2011 $3.77B $454M -$782M -63.3% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-27
Q2 2011 $4.55B $1.17B -$32M -2.66% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-27
Q1 2011 $4.59B $1.13B -$42M -3.6% Jan 1, 2011 Mar 31, 2011 10-K 2013-02-27
Q4 2010 $4.63B $1.02B Oct 1, 2010 Dec 31, 2010 10-K 2012-02-29
Q3 2010 $1.24B Jul 1, 2010 Sep 30, 2010 10-K 2012-02-29
Q2 2010 $1.2B Apr 1, 2010 Jun 30, 2010 10-K 2012-02-29
Q1 2010 $1.17B Jan 1, 2010 Mar 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.